Back to search

National and Kapodistrian University of Athens

Cardiovascular risk stratification in patients with systemic lupus erythematosus and antiphospholipid syndrome

Abstract

dc:description

Background. Complex interactions between traditional and disease-related risk factors lead to increased cardiovascular risk (CVR) in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). There is currently an evidence gap regarding which risk indicators reported by the European Society of Cardiology (ESC) and the European Alliance for Associations in Rheumatology (EULAR) should be used to assess CVR to optimise modifiable risk factor management (blood pressure, BP; lipids) in SLE and APS. Objective. The aim of this dissertation was to assess the performance of risk prediction models for identifying high CVR due to the presence of vascular ultrasound (VUS)-detected subclinical atherosclerosis and to examine the impact of different risk classification strategies to guide the treatment of BP (BPT) and lipids (LT) in patients with SLE and/or APS. Methods. The study enrolled 331 adult patients with SLE and/or APS, without previous atherosclerotic cardiovascular events, diabetes mellitus (DM) or advanced kidney disease, followed up at the CVR Research Laboratory of the First Department of Propaedeutic Internal Medicine of the National and Kapodistrian University of Athens, Greece. Participants were risk-classified according to Systematic Coronary Risk Evaluation (SCORE), modified SCORE (mSCORE), Framingham Risk Score (FRS), Pooled Cohorts Risk Equation, Globorisk, Prospective Cardiovascular Münster Study risk calculator in addition to the QRESEARCH risk estimator version 3 (QRISK3) and the modified FRS (mFRS) for SLE cases and the Second Manifestations of Arterial Disease (SMART), adjusted Global APS Score (aGAPSS) and aGAPSS for cardiovascular disease (aGAPSSCVD) for APS cases. All patients underwent VUS examination of the carotid and femoral arteries for the presence of subclinical atherosclerotic plaques. The risk classification modalities examined to determine eligibility for BPT and LT included SCORE, mSCORE or DM-equivalent risk qualifiers (DIME) alone or in addition to disease-specific risk classifiers and VUS-detected atherosclerotic plaques. For all CVR prediction models, calibration (Spiegelhalter’s z-test), discrimination (area under the receiver operating characteristic curve, AUROC) and classification ability (Matthews’ correlation coefficient, MCC) were assessed. Following ESC recommendations, VUS-based reclassification was applied to non-high-risk cases to identify actual high risk due to the presence of plaques. Agreement between actual risk-stratified eligibility for BP and lipid management based on ESC-reported CVR predictors and eligibility according to EULAR potential risk classifiers was tested using Cohen’s kappa. Results. 210 SLE (mean age: 45 years; women: 93%) and 121 APS (mean age: 46 years; women: 69%; SLE-APS: 37%) patients were examined. Moderate calibration was observed for all CVR prediction models examined (z-test p value 0.38–0.63 in SLE and 0.47–0.57 in APS). AUROC values ranged from 0.73 to 0.84 for SLE and 0.56 to 0.75 for APS, indicating acceptable to excellent and poor to acceptable discrimination, respectively. The classification ability for all models was fair to good in SLE (MCC 0.25–0.47) and negligible to moderate in APS (MCC 0.01–0.35). In SLE patients, Globorisk and QRISK3 outperformed all other generic and disease-adapted models, respectively. In the APS group, all generic models performed poorly, while SMART and aGAPSSCVD (only for non-triple antiphospholipid antibody-positive (aPLpos) patients) performed better than aGAPSS. VUS-based high-risk reclassification was 10%–28% in SLE and 34%–53% in APS; reclassification rates were higher for generic models in SLE and for SMART, aGAPSS and aGAPSSCVD in APS. In SCORE-predicted low/moderate-risk SLE patients, eligibility for LT was 0.6% versus 19% using SCORE alone versus SCORE plus VUS (reference qualifier); SCORE plus glucocorticoid use and SCORE plus aPLpos showed fair agreement (kappa >0.20) with SCORE plus VUS. In APS, the most reliable (kappa >0.40) risk classification strategies to determine eligibility were DIME alone or in addition to aPLpos or type of vascular thrombosis (APSevents) for BPT and SCORE (or mSCORE) plus APSevents or DIME plus aPLpos for LT. No combination of traditional (SCORE/mSCORE, DIME) and disease-related risk classifiers (aPLpos, APSevents) achieved an equally acceptable level of agreement across all actual risk classes for both BPT and LT. Conclusion. The evidence gained through the work of this dissertation indicates that the majority of currently available generic and disease-related risk algorithms underestimate actual high CVR in SLE and APS, suggesting that their use without additional risk assessment modalities would compromise optimal cardiovascular disease prevention in these diseases. In particular, the use of SCORE (and mSCORE) alone to initiate BPT and LT would be discouraged in apparently non-high-risk patients. The use of VUS could contribute to better management of CVR factors, although considering disease-related risk factors also appears important. These results highlight the need for multimodal CVR assessment to improve cardiovascular health in people with SLE and APS.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Drosos, Georgios
  • Δρόσος, Γεώργιος

Subjects

dc:subject × 16

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/56236

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Drosos, Georgios; Δρόσος, Γεώργιος. Cardiovascular risk stratification in patients with systemic lupus erythematosus and antiphospholipid syndrome. National and Kapodistrian University of Athens, 2024. http://hdl.handle.net/10442/hedi/56236